Skip to main content

Currently Skimming:

Appendix D-11: The Prospects for Immunizing Against Rabies Virus
Pages 287-298

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 287...
... _ . Rabies is a rapidly progressive and uniformly fatal viral meningoencephalitis in humans caused by the bullet-shaped viral particles of the rabies group of Rhabdoviridae, genus Lyssavirus (Shope, 19841.
From page 288...
... Immunological and neurological complications occur at low frequencies; neurological complications, including postvaccinal encephalitis and transient neuroparalytic illness, occur in 1:25,000 vaccinees and lead to death in 1:225,000 (Rubin et al., 1969~. The DEV remains the major rabies vaccine in many parts of the world.
From page 289...
... Attenuation of rabies virus has been shown to be related to replacement of arginine in position 333 by either isoleucine or glutamine in the viral glycoprotein {World Health Organization, 1984~. Virus adapted to laboratory conditions is characterized by a fixed and shortened incubation period and by a tendency for viral particles to bud from the plasma membranes rather than from intracytoplasmic membranes as is typical of wild virus (Shope, 1984~.
From page 290...
... The effect of T particles on the development of the immune response is not clear, although they may prolong the incubation period and allow more time for post-exposure prophylaxis. DISTRIBUTION OF DISEASE Geographic Distribution Canine rabies is enzootic in at least 87 countries and on every continent except Australia.
From page 291...
... Other figures are based on information from the World Health Organization {1984j. Population figures for calculating rates are from the 1984 World Population Data Sheet (Population Reference Bureau, 1984~.
From page 293...
... 293 s4 0 p4 lo To so 0 a, PA l UP U)
From page 294...
... The main role of a rabies vaccine for humans is to provide postexposure prophylaxis for dog and other animal bites. Post-exposure prophylactic regimens have been published widely (American Public Health Association, 1985)
From page 295...
... dog control through immunization and registration of family pets, and destruction of stray populations (control efforts could include animal contraception and mass immunization of dogs in endemic areas)
From page 296...
... DEV has the advantage of being relatively inexpensive. An alternative cell culture medium is a continuous, aneuploid cell line derived from the vervet monkey kidney, called Vero (WHO Expert Committee on Rabies, 1984~.
From page 297...
... 1984. Immunogenicity of a new, highly purified and concentrated duck embryo rabies vaccine.
From page 298...
... 1984. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.